Wex Pharmaceuticals Inc. Announces Addition of Intellectual Property For Its Novel Development and Use of Tetrodotoxin (Ttx) to Relieve Pain
VANCOUVER, BC — WEX Pharmaceuticals Inc. (“WEX”, or the “Company”), a biopharmaceutical company based in Vancouver, Canada developing a non-opioid analgesic, Halneuron® (“tetrodotoxin” or “TTX”), today announced the publication of… Read More




